Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126718391 | 12671839 | 1 | I | 20141231 | 20160818 | 20160822 | 20160822 | EXP | US-GLAXOSMITHKLINE-US2016120262 | GLAXOSMITHKLINE | 62.67 | YR | F | Y | 0.00000 | 20160822 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126718391 | 12671839 | 1 | PS | LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1 | Oral | 1 G, BID | U | 21654 | 1 | G | CAPSULE | BID | |||||
| 126718391 | 12671839 | 2 | SS | LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1 | U | 21654 | CAPSULE | ||||||||||
| 126718391 | 12671839 | 3 | SS | OMEGA-3-ACID ETHYL ESTERS. | OMEGA-3-ACID ETHYL ESTERS | 1 | Oral | 1 G, BID | Y | 21654 | 1 | G | CAPSULE | BID | |||||
| 126718391 | 12671839 | 4 | SS | OMEGA-3-ACID ETHYL ESTERS. | OMEGA-3-ACID ETHYL ESTERS | 1 | Y | 21654 | CAPSULE | ||||||||||
| 126718391 | 12671839 | 5 | C | BLACK ELDERBERRY | 2 | U | 0 | ||||||||||||
| 126718391 | 12671839 | 6 | C | COMBIGAN | BRIMONIDINE TARTRATETIMOLOL MALEATE | 1 | U | 0 | |||||||||||
| 126718391 | 12671839 | 7 | C | ECHINACEA AND GOLDENSEAL | 2 | U | 0 | ||||||||||||
| 126718391 | 12671839 | 8 | C | ESTER C | 2 | U | 0 | ||||||||||||
| 126718391 | 12671839 | 9 | C | GLUCOSAMINE CHONDROITIN | CHONDROITIN SULFATE (BOVINE)GLUCOSAMINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126718391 | 12671839 | 10 | C | TEA | TEA LEAF | 1 | U | 0 | |||||||||||
| 126718391 | 12671839 | 11 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | U | 0 | |||||||||||
| 126718391 | 12671839 | 12 | C | LUMIGAN | BIMATOPROST | 1 | U | 0 | |||||||||||
| 126718391 | 12671839 | 13 | C | MAGNESIUM | MAGNESIUM | 1 | U | 0 | |||||||||||
| 126718391 | 12671839 | 14 | C | OIL OF OREGANO | 2 | U | 0 | ||||||||||||
| 126718391 | 12671839 | 15 | C | RESVERATROL | RESVERATROL | 1 | U | 0 | |||||||||||
| 126718391 | 12671839 | 16 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | U | 0 | |||||||||||
| 126718391 | 12671839 | 17 | C | GEMFIBROZIL. | GEMFIBROZIL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126718391 | 12671839 | 1 | Blood cholesterol increased |
| 126718391 | 12671839 | 2 | Blood triglycerides increased |
| 126718391 | 12671839 | 3 | Blood cholesterol increased |
| 126718391 | 12671839 | 4 | Blood triglycerides increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126718391 | 12671839 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126718391 | 12671839 | Dyspepsia | |
| 126718391 | 12671839 | Glaucoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126718391 | 12671839 | 3 | 201410 | 0 |